Skip to main content

Table 3 Gene sets enrichment analysis of high METTL14 mRNA expression level in the ccRCC cohort

From: Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

Gene set name NES NOM p-val FDR q-val
KEGG_ERBB_SIGNALING_PATHWAY 2.346 0.000 0.001
KEGG_MAPK_SIGNALING_PATHWAY 2.384 0.000 0.001
KEGG_MTOR_SIGNALING_PATHWAY 2.295 0.000 0.001
KEGG_PATHWAYS_IN_CANCER 2.279 0.000 0.001
KEGG_RENAL_CELL_CARCINOMA 2.279 0.000 0.001
KEGG_TGF_BETA_SIGNALING_PATHWAY 2.284 0.000 0.001
KEGG_WNT_SIGNALING_PATHWAY 2.312 0.000 0.001
  1. NES normalized enrichment score, NOM nominal, FDR false discovery rate. Gene sets with NOM p-val < 0.01 and FDR q-val < 0.01 are considered as significant